7 results
6-K
EX-99.1
BYSI
BeyondSpring Inc
11 Jan 22
BeyondSpring Announces Organizational Streamlining
4:50pm
is a necessary step forward for the Company to deliver on its mission to develop innovative cancer therapies and improve clinical outcomes
6-K
EX-99.1
BYSI
BeyondSpring Inc
13 Nov 20
BeyondSpring Subsidiary, Seed Therapeutics, Announces Research Collaboration and License Agreement with Lilly
7:28am
by a comprehensive intellectual property portfolio, Seed Therapeutics' mission is to positively impact human health by creating novel protein degradation therapeutics
6-K
EX-99.1
gnhri
3 Sep 20
BeyondSpring Provides Second-Quarter 2020 Financial Results and Business Updates
8:00am
6-K
EX-99.1
hut05du3igsg0
15 Jun 20
Current report (foreign)
4:39pm
- Prev
- 1
- Next